Along these lines, an earlier study in COVID-19 patients showed significantly greater levels of activated IL-17A-producing γδ T cells with decreased levels of IFN-γ-production among other innate T cells in the peripheral blood17. This evidence concerns the gene IL17A and COVID-19.